Loading organizations...
Think.Health Ventures operates as a specialized venture capital firm, focusing its investments within the dynamic healthcare sector. The firm strategically deploys capital into innovative and disruptive business models, with a particular emphasis on digital healthcare solutions, life sciences, pharmaceuticals, and biotechnology. Its approach targets early-stage companies poised to reshape the industry through technological advancements and novel service delivery.
The firm was founded by Dr. Florian Kainzinger, establishing its base in Fürstenfeldbruck, Germany. The genesis of Think.Health Ventures stemmed from an identified opportunity to support entrepreneurial endeavors within the evolving healthcare landscape. Kainzinger's insight centered on the critical need for dedicated investment in companies that aim to drive significant progress and efficiency across various healthcare domains.
Think.Health Ventures' primary "customers" are the emerging companies it chooses to fund, providing them with essential capital and strategic guidance. The firm's long-term vision is to foster the development of a robust ecosystem of healthcare innovators. It endeavors to accelerate the growth of enterprises that are not only financially promising but also contribute meaningfully to the advancement of patient care and health outcomes globally.
Key people at Think.Health Ventures.
Think.Health Ventures was founded in 2015 by Dr. Florian Kainzinger (Managing Partner & Founder).
Think.Health Ventures has 8 tracked investments across 7 companies. The latest tracked deal is $5.5M Series C in Sphingotec GmbH in August 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 8, 2024 | Sphingotec GmbH | $5.5M Series C | Think.health Ventures | — |
| Jan 31, 2024 | Myo | $8.7M Series A | Sascha Berger | Agaplesion, Axel Springer Plug And Play, BonVenture, Capacura, Carpediem Capital, Mountain Partners, Round Hill Ventures, Stefan Fischer, Twip |
| Nov 11, 2022 | Navignostics | $7.8M Seed | Frank Laukien | Ventura BioMed Investors, Zürcher Kantonalbank |
| Oct 21, 2022 | anvajo | $17.3M Series A | — | Brueckenkoepfe Management, Elber Beteiligungen, Johnsonville Holdings, Medice Arzneimittel |
| Sep 28, 2021 | Smarterials | $1.2M Seed | Fabian Mohr | Emanet |
| Jan 1, 2020 | Caspar Health | $6.0M Series A | Bernd Klosterkemper | Helmut C. Nanz, Atlantic Labs, Helmut C. Nanz |
| Jan 20, 2019 | First Light Diagnostics | $8.3M Series A | — | 10X Group, Beacon Angels, Life Science Angels, Lrvhealth |
| Dec 4, 2017 | Caspar Health | $3.6M Seed | — | Christophe Maire |
Key people at Think.Health Ventures.